Last reviewed · How we verify
NG-Monomethyl-L-Arginine
NG-Monomethyl-L-Arginine is a Small molecule drug developed by VA Office of Research and Development. It is currently in Phase 2 development. Also known as: LNMMA, L-NMMA.
At a glance
| Generic name | NG-Monomethyl-L-Arginine |
|---|---|
| Also known as | LNMMA, L-NMMA |
| Sponsor | VA Office of Research and Development |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) (PHASE2)
- Passive Limb Movement: A Tool to Assess Vascular Health and Guide Rehabilitation
- : Vascular Function in Health and Disease (PHASE1)
- Mechanisms of Vasovagal Syncope (EARLY_PHASE1)
- Phase Ib of L-NMMA and Pembrolizumab (PHASE1)
- Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF) (PHASE2)
- L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (PHASE1, PHASE2)
- Prostacyclin (PGI2) Pathway to Enhance Wound Healing in Diabetic Foot Ulcers (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NG-Monomethyl-L-Arginine CI brief — competitive landscape report
- NG-Monomethyl-L-Arginine updates RSS · CI watch RSS
- VA Office of Research and Development portfolio CI
Frequently asked questions about NG-Monomethyl-L-Arginine
What is NG-Monomethyl-L-Arginine?
NG-Monomethyl-L-Arginine is a Small molecule drug developed by VA Office of Research and Development.
Who makes NG-Monomethyl-L-Arginine?
NG-Monomethyl-L-Arginine is developed by VA Office of Research and Development (see full VA Office of Research and Development pipeline at /company/va-office-of-research-and-development).
Is NG-Monomethyl-L-Arginine also known as anything else?
NG-Monomethyl-L-Arginine is also known as LNMMA, L-NMMA.
What development phase is NG-Monomethyl-L-Arginine in?
NG-Monomethyl-L-Arginine is in Phase 2.
Related
- Manufacturer: VA Office of Research and Development — full pipeline
- Also known as: LNMMA, L-NMMA
- Compare: NG-Monomethyl-L-Arginine vs similar drugs
- Pricing: NG-Monomethyl-L-Arginine cost, discount & access